References
- Bloom CI, Saglani S, Feary J, et al. Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006–2016. Eur Respir J. Internet]. 2019 [cited 2021 Mar 8];53. Available from: http://erj.ersjournals.com/lookup/doi/https://doi.org/10.1183/13993003.02130-2018
- Mukherjee M, Stoddart A, Gupta RP, et al. The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases. BMC Med. 2016;14:113.
- Haughney J, Gruffydd-Jones K, Roberts J, et al. The distribution of COPD in UK general practice using the new GOLD classification. Eur Respir J. 2014;43:993–1002.
- Snell N, Strachan D, Hubbard R, et al. S32 Epidemiology of chronic obstructive pulmonary disease (COPD) in the UK: findings from the British lung foundation’s ‘respiratory health of the nation’ project. Thorax. 2016;71:A20.1–A20.
- Nissen F, Morales DR, Mullerova H, et al. Concomitant diagnosis of asthma and COPD: a quantitative study in UK primary care. Br J Gen Pract. 2018;68:e775–e782.
- Tinkelman DG, Price DB, Nordyke RJ, et al. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma Off J Assoc Care Asthma. 2006;43:75–80.
- Su N, Lin J, Chen P, et al. Evaluation of asthma control and patient’s perception of asthma: findings and analysis of a nationwide questionnaire-based survey in China. J Asthma. 2013;50:861–870.
- Schultze A, Walker AJ, MacKenna B, et al. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir Med. 2020;8:1106–1120.
- Centers for Disease Control and Prevention. COVID-19 and Your Health [Internet]. Cent. Dis. Control Prev. 2020 [cited 2021 Mar 8]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html.
- National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease in over 16s: diagnosis and management Guidance [Internet]. NICE; 2018 [cited 2021 Mar 8]. Available from: https://www.nice.org.uk/guidance/ng115.
- Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–365.
- Boulet L-P, Reddel HK, Bateman E, et al. The Global Initiative for Asthma (GINA): 25 years later. Eur Respir J. 2019;54(2):1900598
- Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31:143–178. Eur Respir J. 2018;51.
- Oreskovic NM, Kinane TB, Aryee E, et al. The Unexpected Risks of COVID-19 on Asthma Control in Children. J Allergy Clin Immunol Pract. 2020;8:2489–2491.
- Baptist AP, Lowe D, Sarsour N, et al. Asthma disparities during the COVID-19 pandemic: a survey of patients and physicians. J Allergy Clin Immunol Pract. 2020;8(3371–3377.e1):3371–3377.e1.
- Kaye L, Theye B, Smeenk I, et al. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2020;8:2384–2385.
- Underner M, Taillé C, Peiffer G, et al. [COVID-19 and asthma control]. Rev Mal Respir. 2021;38:111–113.
- Chang C, Zhang L, Dong F, et al. Asthma control, self-management, and healthcare access during the COVID-19 epidemic in Beijing. Allergy. 2021;76:586–588.
- Restrepo RD, Alvarez MT, Wittnebel LD, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:371–384.
- Jepson G, Butler T, Gregory D, et al. Prescribing patterns for asthma by general practitioners in six European countries. Respir Med. 2000;94:578–583.
- English Prescribing Dataset (EPD) - open data portal BETA [Internet]. [cited 2020 Apr 25]. Available from https://opendata.nhsbsa.net/dataset/english-prescribing-data-epd.
- Office for national statistics. vital statistics in the UK: births, deaths and marriages - office for national statistics [Internet]. 2021 [cited 2021 Mar 19]. Available from https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/vitalstatisticspopulationandhealthreferencetables.
- Office for National Statistics. Deaths registered monthly in England and Wales - Office for National Statistics [Internet]. [cited 2021 Mar 19]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/datasets/monthlyfiguresondeathsregisteredbyareaofusualresidence.
- Office for national statistics. provisional births in England and Wales [Internet]. [cited 2021 Mar 19]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/livebirths/datasets/provisionalbirthsinenglandandwales.
- Singh D, Halpin DMG. Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying?. Lancet Respir Med. 2020;8:1065–1066.
- Benchimol EI, Smeeth L, Guttmann A, et al. The Reporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12:e1001885.
- Cochrane Effective Practice and Organisation of Care (EPOC). Interrupted time series (ITS) analyses. EPOC Resources for review authors [Internet]. 2017. [cited 2020 Nov 27]. Available from: epoc.cochrane.org/resources/epoc-specific-resources-review-authors.
- Lopez Bernal J, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2016;46(1):348–355.
- Kontopantelis E, Doran T, Springate DA, et al. Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis. BMJ. 2015;350:h2750–h2750.
- European Medicines Agency. Shortages catalogue. Internet]. Eur Med Agency. 2018 [cited 2020 Aug 6]. Available from https://www.ema.europa.eu/en/human-regulatory/post-authorisation/availability-medicines/shortages-catalogue
- European Medicines Agency. Availability of medicines. Internet]. Eur Med Agency. 2018 [cited 2020 Aug 6]. Available from https://www.ema.europa.eu/en/human-regulatory/post-authorisation/availability-medicines
- Clews G, Manufacturing problems cause 60% of medicines shortages, say European wholesalers. Pharm J. 2019;Internet] [cited 2020 Aug 10]. Available from https://www.pharmaceutical-journal.com/news-and-analysis/news/manufacturing-problems-cause-60-of-medicines-shortages-say-european-wholesalers/20207343.article?firstPass=false
- McLean S, Hoogendoorn M, Hoogenveen RT, et al. Projecting the COPD population and costs in England and Scotland: 2011 to 2030. Sci Rep. 2016;6:31893.